Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Sep 14;16(9):e0257425.
doi: 10.1371/journal.pone.0257425. eCollection 2021.

Prognostic role of the prognostic nutritional index (PNI) in patients with head and neck neoplasms undergoing radiotherapy: A meta-analysis

Affiliations
Meta-Analysis

Prognostic role of the prognostic nutritional index (PNI) in patients with head and neck neoplasms undergoing radiotherapy: A meta-analysis

Yujie Shi et al. PLoS One. .

Abstract

Background: This novel meta-analysis was conducted to systematically and comprehensively evaluate the prognostic role of the pretreatment PNI in patients with head and neck neoplasms (HNNs) undergoing radiotherapy.

Methods: Three databases, PubMed, Embase, and Web of Science, were used to retrieve desired literature. Hazard ratios (HRs) with 95% confidence intervals (CIs) were extracted and pooled by fixed-effects or random-effects models to analyze the relationship between the PNI and survival outcomes: overall survival (OS), distant metastasis-free survival (DMFS), and progression-free survival (PFS).

Results: Ten eligible studies involving 3,458 HNN patients were included in our analysis. The robustness of the pooled results was ensured by heterogeneity tests (I2 = 22.6%, 0.0%, and 0.0% for OS, DMFS, and PFS, respectively). The fixed-effects model revealed a lower pretreatment PNI was significantly related to a worse OS (HR = 1.974; 95% CI: 1.642-2.373; P<0.001), DMFS (HR = 1.959; 95% CI: 1.599-2.401; P<0.001), and PFS (HR = 1.498; 95% CI: 1.219-1.842; P<0.001). The trim-and-fill method (HR = 1.877; 95% CI: 1.361-2.589) was also used to prove that the existing publication bias did not deteriorate the reliability of the relationship.

Conclusion: The pretreatment PNI is a promising indicator to evaluate and predict the long-term prognostic survival outcomes in HNN patients undergoing radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow diagram of study selection procedure.
Fig 2
Fig 2
Forest plots of the relationship between the PNI and survival outcomes: A. OS B. DMFS C. PFS.
Fig 3
Fig 3
Sensitivity analyses of HRs: A. OS B. DMFS C. PFS.
Fig 4
Fig 4
Test results of publication bias: A. before trim-and-fill method B. after trim-and-fill method.

Similar articles

Cited by

References

    1. Paterson C, Hargreaves S, Rumley CN. Functional Imaging to Predict Treatment Response in Head and Neck Cancer: How Close are We to Biologically Adaptive Radiotherapy? Clinical oncology (Royal College of Radiologists (Great Britain)). 2020;32(12):861–73. doi: 10.1016/j.clon.2020.10.004 - DOI - PubMed
    1. Hoesseini A, Offerman MPJ, van de Wall-Neecke BJ, Sewnaik A, Wieringa MH, Baatenburg de Jong RJ. Physicians’ clinical prediction of survival in head and neck cancer patients in the palliative phase. BMC palliative care. 2020;19(1). doi: 10.1186/s12904-020-00682-2 - DOI - PMC - PubMed
    1. Ribeiro LN, Lima MH, Carvalho AT, Albuquerque RF, Leao JC, Silva IH. Evaluation of the salivary function of patients in treatment with radiotherapy for head and neck cancer submitted to photobiomodulation. Medicina oral, patologia oral y cirugia bucal. 2021;26(1):e14–e20. doi: 10.4317/medoral.23912 - DOI - PMC - PubMed
    1. Kawashita Y, Soutome S, Umeda M, Saito T. Oral management strategies for radiotherapy of head and neck cancer. The Japanese dental science review. 2020;56(1):62–7. doi: 10.1016/j.jdsr.2020.02.001 - DOI - PMC - PubMed
    1. Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi: 10.1016/S0140-6736(19)30956-0 - DOI - PubMed

Publication types

Grants and funding

The authors received no specific funding for this work.